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Clinical ResearchThe Learning Curve in Percutaneous Repair
of Paravalvular Prosthetic Regurgitation
An Analysis of 200 Cases
Paul Sorajja, MD,* Allison K. Cabalka, MD,y Donald J. Hagler, MD,y
Charanjit S. Rihal, MD*
Rochester, MinnesotaObjectives This study sought to assess the learning curve for percutaneous repair of paravalvular
prosthetic regurgitation.
Background Percutaneous repair of prosthetic paravalvular regurgitation is a complex procedure.
There is a paucity of data on the professional experience and tools needed to achieve optimal clinical
outcomes.
Methods We examined the chronological experience of 200 patients (age 66  13 years; 57% men)
who underwent percutaneous closure of paravalvular prosthetic regurgitation at our institution.
A sequence number of the patient was assigned as a continuous variable for analysis.
Results A total of 243 paravalvular defects (74% mitral; 26% aortic) were treated. Device delivery was
successful in 92% with an average procedural time of 139  47 min. The 30-day rate of major adverse
cardiovascular events was 7%. With increased case experience and adoption of dedicated imaging and
catheter techniques, there were decreases in procedural time, ﬂuoroscopy time, contrast volume
administered, length of hospital stay, and major adverse cardiovascular events. Procedural success
remained unchanged throughout the experience. The predominant reason for procedural failure was
prosthetic leaﬂet impingement, which accounted for 9 of 21 failed cases.
Conclusions In this single-center experience, there was evidence of a learning curve that occurred
with the adoption of dedicated techniques for catheter delivery and echocardiographic imaging. In
experienced operators, the potential for prosthetic leaﬂet impingement is the predominant limitation
of the procedure. These data have implications for physician training and performance in complex
structural heart disease interventions. (J Am Coll Cardiol Intv 2014;7:521–9) ª 2014 by the American
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522Paravalvular regurgitation is a common complication of
prosthetic valves with an estimated incidence of 3% to 6%
among surgical implants (1–3). Patients can have minimal
or no symptoms attributable to paravalvular regurgitation
or can present with heart failure and/or hemolytic anemia.
Percutaneous transcatheter methods for the treatment of
paravalvular regurgitation have emerged. Data from a
number of clinical registries have demonstrated the clinical
efﬁcacy of percutaneous repair, with success rates that
approach 80% to 90% in selected patients (4–12). These
data have led to an increasing number of patients under-
going the procedure, which can avoid the need for repeat
sternotomy and the risks of open cardiac surgery (13–15).
The rapid growth of a variety of transcatheter structural
heart disease interventions has spawned considerable interest
in the expansion of interventional programs to address the
need for physician training in this ﬁeld of expertise (16).
Percutaneous closure of paravalvular prosthetic regurgita-
tion, although an efﬁcacious therapy, is a notably complex
procedure that entails a number of traditional and complex
catheter techniques. Like other structural heart disease in-
terventions, percutaneous closure requires expertise in
techniques that are not commonly used in current physicianAbbreviations
and Acronyms
MACE = major adverse
cardiovascular event(s)
STS = Society of Thoracictraining programs, leading either
to the necessity of performing
these cases at highly specialized
centers or the need for ongoing
on-site proctoring. Thus, for
percutaneous closure of para-
valvular prosthetic regurgitationand many structural heart disease interventions, the clinical
experience required to optimize clinical outcomes remains
unknown (16). To test the hypothesis that a substantial
learning curve exists for this procedure and to gain insight
into the professional experience needed for expertise in
structural heart interventions, we examined the learning
curve for percutaneous repair of prosthetic paravalvular
regurgitation.
Methods
Study population. The Mayo Clinic Institutional Review
Board approved this study. Between February 1, 2004 and
April 9, 2013, 203 patients were clinically evaluated and
underwent percutaneous repair of paravalvular prosthetic
regurgitation at the Mayo Clinic in Rochester, Minnesota.
Patients with the following clinical criteria were considered
for percutaneous repair: 1) severe symptoms of dyspnea
or clinically signiﬁcant hemolytic anemia; 2) moderately se-
vere or severe paravalvular prosthetic regurgitation; 3) absence
of active endocarditis; 4) regurgitation involving one-third
or less of the circumference of the prosthetic annulus
and absence of an unstable or rocking prosthesis; and
5) informed consent. Although computed tomography has
Surgeonsbeen used for assessing paravalvular prosthetic regurgitation,
echocardiography was the primary imaging modality for
assessment in these patients. Regurgitation involving one-
third of the circumference of the annulus was used as an
empirical approximation. Informed consent entailed under-
standing the need for off-label use of approved devices,
expected clinical efﬁcacy, risks associated with the complex
catheter techniques (e.g., transseptal access, apical puncture),
and a detailed discussion of potential therapeutic options,
including open cardiac surgery. Clinically signiﬁcant he-
molytic anemia was deﬁned as anemia (typically hemoglobin
<10 g/dl, usually transfusion dependent, with or without
erythropoietin therapy) with laboratory evidence of intra-
vascular hemolysis (i.e., abnormalities on peripheral smear
or in serum levels of antiglobulin antibody, haptoglobin,
lactate dehydrogenase, or reticulocyte count) associated with
symptoms requiring blood transfusion.
Of the patients who underwent percutaneous repair, 3
declined use of their medical record for research. The
remaining 200 patients provided consent to participate in
the study in accordance with Minnesota statutes and form
the cohort for analysis. The present cohort also includes the
patients who were reported in our previous experience with
this therapy (11,12).
Percutaneous repair. Our techniques for percutaneous
repair of paravalvular prosthetic regurgitation have been
described in detail previously (15). In brief, for patients with
paramitral prosthetic regurgitation, standard transseptal ac-
cess was obtained from the femoral vein with placement of a
steerable sheath (e.g., 8.5- or 11-French Agilis catheter [St.
Jude Medical, St. Paul, Minnesota]) in the left atrium. The
deﬂectable tip of this catheter facilitates antegrade crossing
of the defect using an angled-tip, exchange-length glide wire
and placement of delivery catheters into the left ventricle,
with guidance from ﬂuoroscopy and transesophageal echo-
cardiography. For para-aortic defects, a retrograde approach
from the femoral artery typically is used, usually in con-
junction with transthoracic or intracardiac echocardiogra-
phy. The para-aortic defect is crossed with an angled-tip,
exchange-length glide wire and steerable diagnostic coro-
nary catheters (e.g., 6-French Amplatz Left 1). For both
approaches, either a telescoped coronary guide catheter
(e.g., 125-cm 5-French diagnostic inside a 100-cm 6-
French Multipurpose) or a long delivery sheath (e.g.,
8-French Cook shuttle [Cook Medical, Bloomington,
Indiana]) can be advanced followed by placement of
appropriately sized occluder device(s) (e.g., Amplatzer
Vascular Plug II [St. Jude Medical]). For instances where
increased support was needed to pass delivery catheters,
a transcatheter rail was created. In this method, an ex-
change-length guidewire is snared in a chamber distal to
the initial approach used for crossing the defect (e.g.,
snaring in the left ventricle or aorta for a wire passed ante-
grade from the left atrium) and exteriorized via the femoral
Table 1. Baseline Characteristics (N ¼ 200)
All Patients
Group
p Value1 2 3 4
Age, yrs 66  13 66  12 69  12 67  14 64  14 0.30
Male 115 (58) 29 (58) 24 (48) 29 (58) 33 (66) 0.39
Treated prosthesis type
Aortic 51 (26) 11 (22) 8 (16) 15 (30) 18 (36) 0.14
Mitral 149 (74) 38 (76) 42 (84) 35 (70) 33 (66) 0.14
Bioprostheses 86 (43) 15 (30) 20 (40) 28 (56) 23 (46) 0.08
Mechanical prostheses 114 (57) 34 (68) 30 (60) 22 (44) 28 (56) 0.08
Time of implantation to percutaneous
repair, months
68  84 54  51 84  92 56  69 83  108 0.16
Presenting symptoms
Heart failure 187 (94) 47 (94) 44 (88) 49 (98) 47 (94) 0.19
Hemolytic anemia 62 (31) 20 (40) 21 (42) 12 (24) 9 (18) 0.02
Right heart failure 17 (9) 8 (16) 5 (10) 4 (8) 0 (0) 0.68
Medical history
Coronary artery disease 62 (32) 15 (30) 15 (30) 14 (28) 18 (36) 0.90
Peripheral vascular disease 14 (7) 8 (16) 1 (2) 2 (4) 3 (6) 0.03
Hypertension 97 (48) 29 (58) 20 (40) 25 (50) 23 (46) 0.27
Atrial ﬁbrillation 105 (52) 24 (48) 30 (60) 27 (54) 24 (48) 0.57
Chronic obstructive pulmonary disease 25 (13) 9 (18) 5 (10) 3 (6) 8 (16) 0.24
Previous stroke 37 (19) 8 (16) 14 (28) 9 (18) 6 (12) 0.20
Creatinine clearance, ml/min 65  38 65  41 59  30 62  37 72  44 0.42
<60 105 (53) 26 (52) 27 (54) 30 (60) 26 (52) 0.83
Congenital heart disease 3 (2) 0 (0) 2 (4) 0 (0) 1 (2) 0.30
Radiation heart disease 7 (4) 0 (0) 4 (8) 2 (4) 1 (2) 0.16
Previous procedures
2 sternotomies 106 (53) 16 (32) 15 (30) 7 (14) 7 (14) 0.03
Other left-sided valve replacement* 52 (26) 17 (34) 13 (26) 14 (28) 9 (18) 0.28
2 left-sided mechanical prostheses 35 (17) 13 (26) 7 (14) 7 (14) 8 (16) 0.29
Coronary artery bypass grafting 55 (28) 15 (30) 15 (30) 16 (32) 9 (18) 0.34
Permanent pacemaker 31 (16) 7 (14) 9 (18) 8 (16) 7 (14) 0.94
Implanted deﬁbrillator 6 (3) 3 (6) 1 (2) 1 (2) 1 (2) 0.54
Left ventricular ejection fraction, % 57  12 54  14 56  14 57  11 59  8 0.16
Left ventricular end-diastolic diameter, mm 53  9 51  12 51  7 56  7 54  8 0.04
Left ventricular end-systolic diameter, mm 36  9 37  11 34  8 36  7 36  7 0.60
Right ventricular systolic pressure, mm Hgy 55  19 59  19 51  17 54  19 55  22 0.25
Medications
Beta-receptor antagonists 134 (67) 35 (70) 31 (62) 39 (78) 29 (58) 0.11
ACE inhibitor or ARB 84 (42) 22 (44) 29 (58) 20 (40) 13 (26) 0.01
Diuretic 141 (71) 32 (64) 40 (80) 36 (72) 22 (44) 0.30
Digoxin 47 (23) 12 (24) 17 (34) 14 (28) 4 (8) 0.01
Warfarin 120 (60) 31 (62) 27 (54) 25 (50) 37 (74) 0.09
STS estimated operative mortality 6.3  5.0 6.6  4.8 7.7  6.9 9.8  3.1 5.5  4.3 0.06
Values are mean  SD or n (%). *Valve replacement apart from the prosthesis that was treated percutaneously. yEchocardiographic estimation.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker.
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523artery or, in patients with 2 left-sided mechanical prostheses,
via a sheath placed in the left ventricular apex (15).
For patients with defects that were either eccentric or
difﬁcult to cross, the techniques of anchor wiring or
simultaneous deployment of multiple devices may be used.
In the anchor wire technique, 2 extra stiff, 0.032-inchexchange-length wires are placed in the left ventricle,
followed by placement of a relatively larger sheath (e.g., 8-F
Cook shuttle [Cook Medical]) over 1 of the wires. The
sheath is used to place a device occluder, with the bare wire
left to facilitate rapid recrossing in the event that either a
different device or additional devices are required to treat
Table 2. Procedural Characteristics
General anesthesia 165 (82)
Echocardiography
Intracardiac 22 (11)
Transthoracic 25 (13)
Transesophageal 164 (82)
Perivalvular defects
No. attempted 243
Periaortic 58
Perimitral left ventricle to left atrium 184
Perimitral left ventricle to right atrium 2
No. with device implanted 217
Total devices implanted 289
Patients with multiple defects closed 32
Technique used
Periaortic retrograde 54 (27)
Perimitral
Antegrade transeptal 151 (75)
Right internal jugular vein to left ventricle 2 (1)
Apical puncture 16 (8)
Transaortic exteriorization 61 (31)
Multiple devices for single defect 47 (24)
Retrograde aortic approach 4 (2)
Amplatzer occluder* device used
Atrial septal occluder 14 (7)
Vascular Plug II* 154 (77)
Patent ductal occluder 20 (10)
Ventricular septal occluder 12 (6)
Procedure time, min 139  47
Fluoroscopy time, min 52  29
Contrast used, ml 30  46
Procedure success 178 (89)
Residual regurgitation grade 2 46 (23)
Residual regurgitation grade 3 21 (11)
Length of hospital stay after procedure, days 4.5  5.8
Values are n (%) mean  SD. *St. Jude Medical, St. Paul, Minnesota.
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524the regurgitation. In the simultaneous technique, multiple,
extra support, exchange-length wires (0.032 inches) are
placed across single defect to facilitate placement of mul-
tiple occluders through individual telescoping guiding
catheters (15).
The device occluder is released at the site of paraprosthetic
defect after demonstration of a signiﬁcant reduction in the
regurgitation, conﬁrmation of stability of the occluder, and
absence of interference with prosthesis function. The degree
of paravalvular regurgitation was graded semiquantitatively
using Doppler echocardiography and color-ﬂow imaging
(grade I, mild; grade II, moderate; grade III, moderate to
severe; and grade IV, severe) before and immediately after
the procedure (17,18). When multiple jets were present, the
amounts of regurgitation from the separate jets were totaled
for semiquantitation.
Clinical follow-up. Patients were contacted by telephone,
mailed questionnaire, and clinical visit to determine vital
status and adverse events within 30 days of the procedure.
Major bleeding was deﬁned according to Bleeding Aca-
demic Research Consortium criteria (19). Sudden cardiac
death was deﬁned as instantaneous and unexpected death
with or without documented ventricular ﬁbrillation within
1 h after a witnessed collapse, in patients who previously
were in stable clinical condition or nocturnal death with no
history of worsening symptoms. Appropriate discharge of an
implanted internal cardioverter-deﬁbrillator for therapy of a
lethal arrhythmia (i.e., sustained ventricular tachycardia or
ﬁbrillation) was considered to be sudden cardiac death (20).
Occurrence of stroke was deﬁned according to standard
criteria (21).
Data analysis. Procedure order of the patient was assigned
as a continuous variable for the cohort. Acute procedural
success was deﬁned as successful deployment of an occluder
device that resulted in signiﬁcant reduction (1 grade)
in paravalvular regurgitation to moderate or less residual
regurgitation, in the absence of the need for emergency
surgery, leaﬂet impingement, or procedural death. In the
presence of multiple defects, the sum of regurgitation from
these defects, including those not treated, was used. Device
deployment success was deﬁned as any permanent placement
of a device occluder in a paravalvular prosthetic defect
without embolization or leaﬂet impingement. Major adverse
cardiovascular events (MACE) were deﬁned as occurrence
of death, stroke, myocardial infarction, emergency surgery,
or major bleeding (Bleeding Academic Research Con-
sortium criteria 3 or 5) (19). Risk of open surgical repair for
each patient was calculated using the Society of Thoracic
Surgeons (STS) database scoring system (22). Procedure
time was deﬁned as time from placement of the patient on
the table for cardiac catheterization until the time when the
procedure was stopped and the processes were begun to
remove the patient from the table (e.g., undraping) as noted
in the case log. Patients were stratiﬁed into 4 groups bysequence for analysis: group 1, cases 1 to 49; group 2, cases
50 to 99; group 3, cases 100 to 149; and group 4, cases 150
or later. For symmetrically distributed data, analysis of
variance was used for comparison. For comparison of skewed
data, the Kruskal-Wallis test was used. Continuous variables
are reported as mean  SD unless reported otherwise.Results
Patients. Overall, 200 patients were treated with percuta-
neous repair of paravalvular prosthetic regurgitation (mean
age 66  13 years; 57% men) (Table 1). Heart failure was
the predominant clinical indication for the procedure (94%),
with hemolytic anemia also being present in 31%. Signiﬁ-
cant patient morbidity was common. The majority of the
patients had undergone multiple sternotomies for cardiac
Table 3. Reasons for Procedural Failure
Prosthetic leaﬂet impingement* 8
Device deployed with residual severe regurgitation 6
Device embolization 5
Inability to cross with guidewire 3
Inability to cross with delivery sheath 2
Coronary dissection 1
*1 patient with prosthetic leaﬂet impingement required emergent cardiac surgery.
Figure 1. Procedure Time (Y-Axis) According to Procedure Sequence
(X-Axis)
With increased case experience, there was a signiﬁcant reduction in time
required to complete percutaneous repair of paravalvular prosthetic
regurgitation.
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525surgery (53%). For the entire cohort, the STS estimated
operative mortality was 6.3  5% (range 0.9% to 33.7%).
Procedures. Procedures in a total of 243 defects were
attempted, with the majority being mitral (74%) or involving
mechanical prosthetic valves (57%) (Table 2). Devices were
successfully deployed in 184 patients (92%) with a mean
overall procedure time of 138  48 min. Acute procedural
success occurred in 89.5%; the most common reason for
failure was prosthetic leaﬂet impingement (Table 3). A
transcatheter heart rail was used in 61 patients (31%). In 47
patients (24%), multiple devices, using either multiple
simultaneous guides or the anchor-wire technique, were
placed in single defects to achieve successful reduction in
regurgitation. In 16 patients (8%), direct apical puncture was
required for passage of the delivery catheter across the para-
valvular defect. The overall MACE rate at 30 days was
7% (Table 4). There were 5 cases of device embolization.Table 4. Procedural and 30-Day Events
Total
Quartile
1st 2nd 3rd 4th
Intraprocedural device embolization 4 (2.0) 1 (2.0) 2 (4.0) 0 (0.0) 1 (2.0)
Major bleeding 8 (4.1) 5 (10.0) 2 (4.0) 0 (0.0) 1 (2.0)
Vascular complication 2 (1.0) 1 (2.0) 1 (2.0) 0 (0.0) 0 (0.0)
Hemothorax 5 (2.5) 4 (8.0) 0 (0.0) 0 (0.0) 1 (2.0)
Intracranial hemorrhage 1 (0.5) 0 (0.0) 1 (2.0) 0 (0.0) 0 (0.0)
Embolic stroke 2 (1.0) 1 (2.0) 1 (2.0) 0 (0.0) 0 (0.0)
Emergency cardiac surgery 2 (1.0) 0 (0.0) 1 (2.0) 1 (2.0) 0 (0.0)
For prosthetic impingement 1 (0.5) 0 (0.0) 1 (2.0) 0 (0.0) 0 (0.0)
For device embolization 1 (0.5) 0 (0.0) 0 (0.0) 1 (2.0) 0 (0.0)
Coronary dissection 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.0)
Elective cardiac surgery for
unsuccessful repair*
3 (1.6) 1 (2.0) 3 (6.0) 0 (0.0) 0 (0.0)
Death 4 (2.0) 2 (4.0) 1 (2.0) 1 (2.0) 0 (0.0)
Sudden death 1 (0.5) 1 (2.0) 0 (0.0) 0 (0.0) 0 (0.0)
Cardiac tamponade 1 (0.5) 0 (0.0) 0 (0.0) 1 (2.0) 0 (0.0)
Sepsis 2 (1.0) 1 (2.0) 1 (2.0) 0 (0.0) 0 (0.0)
Death, stroke, or emergency surgery 8 (4.0) 3 (6.0) 3 (6.0) 2 (4.0) 0 (0.0)
Death, stroke, major bleeding, or
emergency surgery
14 (7.3) 8 (16.0) 5 (10.0) 2 (4.0) 1 (2.0)
Values are n (%). *The 3 patients who had elective cardiac surgery each had an uncomplicated,
unsuccessful attempt at percutaneous repair before surgery.Successful percutaneous retrieval using either a snare or a
bioptome was possible in 4 patients; emergent cardiac sur-
gery was required in 1 patient due to device embolization
into the left ventricle in the setting of aortic and mitral
mechanical prostheses. Separately, another patient under-
went emergent cardiac surgery for prosthetic leaﬂet im-
pingement that became evident only after decoupling of the
device from its delivery cable.
Learning curve. Among the 4 groups, there was a nonsig-
niﬁcant trend for higher surgical risk in earlier patients
(p ¼ 0.06 for STS risk score), but there was no change in
patient selection according to location of prosthesis, size, or
location of the defect (Table 1). Compared with the other
groups, patients in group 1 underwent the procedure with
greater use of left ventricular apical puncture for creation of
an arteriovenous rail (22% vs. 0 to 6% in other groups; chi-
square ¼ 18.7; p ¼ 0.0003). Sequential device and anchor
wire techniques were also used almost exclusively for those
in the latter 2 groups (group 3, 48%; group 4, 43%) com-
pared with earlier patients (group 1, 0%; group 2, 4%; chi-
square ¼ 49.4; p < 0.0001). Procedure order was inversely
related to procedure time (p < 0.0001), contrast volume
administered (p ¼ 0.01), ﬂuoroscopy time (p ¼ 0.08), and
length-of-hospital stay (p ¼ 0.007) (Figs. 1 and 2). These
changes plateaued soon after increased use of 3-dimen-
sional echocardiography and more operator experience with
special catheter techniques (e.g., the transcatheter heart rail,
simultaneous device deployment, and anchor wire), with no
signiﬁcant improvements being present in groups 3 and 4
(Fig. 3). Of note, although the effects of 3-dimensional
echocardiography may be difﬁcult to separate from those
of other techniques, there was no signiﬁcant association of
Figure 2. Case Experience and Procedural Changes
Procedure time (top left), ﬂuoroscopy time (bottom left), contrast volume administered (top right), and length of hospital stay (bottom right) improved with
increased case experience. ANOVA - analysis of variance.
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526procedure number with procedure duration, contrast vol-
ume, or length of stay among patients who had 3-dimen-
sional echocardiography.
Notably, the relationship of procedure order to procedure
duration (p < 0.0001), contrast volume administered (p ¼
0.003), and length of hospital stay (p ¼ 0.04) was evident in
patients with defects involving mitral prostheses as well as
aortic prostheses (p ¼ 0.05, p ¼ 0.04, and p ¼ 0.09,
respectively).
There were no differences in the achievement of device
deployment (range for 4 groups, 86% to 94%) or acute
procedure success over the course of the clinical experience.
The predominant reason for failure was prosthetic leaﬂet
impingement, which accounted for 9 of 21 failed cases
(Table 3). The incidence of prosthetic impingement that
could not be avoided during device placement was 4%
and was slightly higher for mechanical valves (7 of 114 or
6.1%) than for bioprostheses (1 of 86 patients or 1.2%;
chi-square ¼ 3.2; p ¼ 0.08). Prosthetic leaﬂet impinge-
ment, inability to cross with either the guidewire or delivery
sheath, persistent severe regurgitation despite deploymentof an occluder, and device embolization occurred in both
early and later patient groups.
There was a lower rate of 30-day MACE with increased
clinical experience (Fig. 4). The higher rate of MACE in the
earliest experience (group 1) was due to bleeding from apical
puncture in 4 patients, unexplained sudden death in 1 pa-
tient, and stroke related to transition of anticoagulation in 1
patient (Table 4). Among the patients in the remaining
groups, MACE rates ranged from 2% to 4% (Fig. 3).Discussion
The principal ﬁndings of this investigation are the following:
1) percutaneous repair of paravalvular prosthetic regurgita-
tion is a complex procedure with a learning curve that
improves with experience in dedicated techniques for cath-
eter delivery and imaging; 2) this learning curve shows re-
ductions in procedure duration, ﬂuoroscopy time, length of
hospital stay, and MACE; and 3) achievement of procedure
success is largely unaffected by clinical experience, primarily
Figure 3. MACE and Procedural Failure According to Case Experience
Changes in major adverse cardiovascular events (MACE) (top), procedural
failure (middle), and the combination of MACE or procedural failure (bot-
tom), with increased case experience. MACE ¼ major adverse cardiovascular
event(s).
Figure 4. Use of Dedicated Techniques According to Procedure
Sequence Number
Cumulative experience with dedicated techniques for imaging and device
delivery according to procedure sequence number. 3D ¼ 3-dimensional.
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527due to the potential for leaﬂet impingement by device
occluders.
Percutaneous transcatheter repair has emerged as an
effective and relatively safe procedure for the treatmentof symptomatic patients with paravalvular prosthetic
regurgitation. The present investigation, which is the largest
examination of this therapy to date, extends previous studies
by demonstrating effective reduction of paravalvular pros-
thetic regurgitation in 89% of patients treated. Notably,
these results were achieved with relatively low rates of pro-
cedural mortality (1%) and MACE (7%), which were
observed in a population at high risk of open surgery (STS
estimated operative mortality ¼ 6.3%). These data support
the notion that percutaneous repair is a viable therapeutic
alternative to open surgical repair, particularly in those pa-
tients who are at increased surgical risk due to the need for
repeat sternotomy and concomitant morbidity (4–14).
Nonetheless, it is well recognized that percutaneous repair
of paravalvular prosthetic regurgitation is a challenging
procedure. The therapy requires expertise in traditional as
well as complex catheter techniques, such as transseptal ac-
cess, manipulation within the left atrium, wire snaring, left
ventricular apical puncture, and creation of wire rails (15).
Percutaneous repair is also associated with unique and
complex complications. Percutaneous device retrieval was
required in 5 patients (4 for embolizations, 1 with leaﬂet
impingement after deployment), whereas 2 others required
emergent cardiac surgery (1 for embolization, 1 for leaﬂet
impingement). Hemothorax, related to left ventricular apical
puncture, also occurred in 5 other patients. Of note, the
technique of apical puncture used was strictly percutaneous,
in contrast to open surgical exposure currently used for
transcatheter valve implantation. Open exposure and use of
closure devices may reduce bleeding related to direct apical
access, which has its own learning curve and should be used
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528only when absolutely necessary for completion of the pro-
cedure (23,24).
The present investigation demonstrates that there is a
signiﬁcant learning curve for percutaneous treatment of
paravalvular prosthetic regurgitation. There were signiﬁcant
decreases in time to complete the procedure, ﬂuoroscopy
exposure, complications (i.e., 30-day MACE), and hospital
length of stay with increased clinical experience, with these
changes reaching a plateau after adoption of dedicated
techniques for imaging and catheter delivery. It is critically
important to note that this learning curve was observed in
the setting of a multidisciplinary team of dedicated operators
(2 adult structural and 2 congenital) and an interventional
imaging service committed to the performance of this proce-
dure. The interventional operators have collaborated closely
and frequently, performing the procedures together to attempt,
to evaluate, and to develop techniques that expedite the care
of these challenging patients. The multidisciplinary team
collaborates on these procedures, which have been increasing
in frequency during the experience (Fig. 5).
This collaborative effort has resulted in signiﬁcant im-
provements in the procedure. The communication between
the interventional operators and echocardiographers has
evolved to rely on language using imaging landmarks for the
co-location of paravalvular leaks, with an emphasis on the
relationships of the left atrial appendage, atrial septum, and
aortic valve using anatomically correct terminology (i.e.,
anterior vs. posterior, inferior vs. superior, lateral vs. medial)
(15). This language emphasizes anatomic orientation for the
entire multidisciplinary team, a key element for expediting
procedure completion. Moreover, there has been increased
technical practice in the snaring and creation of wire rails,
which were necessary for delivery catheter placement in 31%
of the patients. Single defects in the latter cohort of patientsFigure 5. Institutional Case Volume per Year
The number of cases for 2013 is an annualized estimate, using procedural
total through April 14, 2013.were more frequently treated with multiple device occluders.
Improvement in procedural expediency was made possible
with experience in simultaneous and sequential device
deployment using the anchor wire technique, which reduces
the need for de novo rewiring of the defects.
The improvements in operational efﬁciency have impor-
tant implications given the signiﬁcant resources in personnel
needed to perform this therapy. Procedure duration fre-
quently exceeds 2 or 3 h (average time in this study was 139
 47 min). Importantly, these improvements also are note-
worthy as percutaneous repair of paravalvular prosthetic
regurgitation can serve as a learning model because it shares
catheter techniques and imaging requirements with other
structural interventional therapies (e.g., Mitraclip placement,
balloon mitral valvuloplasty, left atrial appendage closure,
device closure of infarct-related ventricular septal defect).
Similar to these other interventions, the techniques of
percutaneous repair of paravalvular prosthetic regurgitation
are not taught routinely in current physician training pro-
grams. Recent expert consensus documents have highlighted
the need for professional training in structural heart disease
interventions due to the rapid growth in this ﬁeld, yet there
are virtually no data on the professional experience required
to optimize clinical outcomes (16,25,26). Therefore, the
learning curve demonstrated in this investigation has im-
plications for the professional training in this rapidly
emerging ﬁeld of expertise.
Prosthetic leaﬂet impingement was the predominant
cause of procedural failure (9 patients or 43% of failed cases),
which occurred with similar frequency throughout the
experience. This complication arises due to device overhang,
which may occur when defects are either close to the sewing
ring or when the lesions are irregular and require relatively
large occluders for closure. Mechanical valves may be more
susceptible to leaﬂet impingement due to the absence of
buttressing struts. To help overcome the potential for leaﬂet
impingement, multiple smaller devices, rather than relatively
large single occluders, were used more commonly in the
latter experience for eccentric defects. Among the patients
who had multiple smaller devices placed in single defects
(n ¼ 46), however, the acute procedural success rate was
90.2% and not different from other patients. Given these
data, the small number of procedural failures overall
(n ¼ 21), and the nonrandomized nature of our study, the
ability to determine the impact of the multiple device
approach on acute procedural success was limited. None-
theless, the present data do support the need for the
development of technology dedicated to the procedure to
reduce the potential for prosthetic leaﬂet impingement and
other complications.
Study limitations. The present investigation is a retrospec-
tive analysis with known inherent limitations, particularly
the potential for referral bias. Data were collected prospec-
tively and entered into a dedicated database for analysis. The
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529cohort consisted of consecutive patients treated at our
institution with the exception of patients who did not pro-
vide informed consent for research use of their medical
record. The echocardiographic evaluation of prosthetic
regurgitation is challenging. The present study used semi-
quantitative methods to determine the degree of regurgita-
tion, which lack the precision of techniques for evaluation of
native valvular regurgitation (17,18).
Conclusions
Percutaneous repair of paravalvular prosthetic regurgitation
is an efﬁcacious procedure with a signiﬁcant learning curve.
As a state-of-the-art therapy that encompasses multiple
complex catheter techniques, these data on percutaneous
repair of paravalvular prosthetic regurgitation have implica-
tions for professional training that are speciﬁc to not only
this procedure, but also for other similar structural heart
disease interventions.
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